Selective internal radiotherapy (SIRT) fails to extend survival in the SORAMIC study palliative cohort

The final results of the palliative cohort of the SORAMIC study in patients with un-resectable, locally advanced primary liver cancer have confirmed no clinical advantage to adding selective internal radiation therapy (SIRT) to standard sorafenib treatment compared with using sorafenib alone.
EurekAlert

Leave a Reply

  • (will not be published)

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>